Kaklamanos, A.; Serepisios, V.; Chelioti, S.; Zervakou, K.; Christodoulou, G.; Pouliakis, A.; Mikelopoulou, K.; Germanou, D.; Tsinokou, I.; Papadakis, D.D.;
et al. Intermediate-Dose Tinzaparin Versus Low-Dose Enoxaparin as Thromboprophylaxis in Hospitalized Internal Medicine Patients. Med. Sci. 2026, 14, 425.
https://doi.org/10.3390/medsci14040425
AMA Style
Kaklamanos A, Serepisios V, Chelioti S, Zervakou K, Christodoulou G, Pouliakis A, Mikelopoulou K, Germanou D, Tsinokou I, Papadakis DD,
et al. Intermediate-Dose Tinzaparin Versus Low-Dose Enoxaparin as Thromboprophylaxis in Hospitalized Internal Medicine Patients. Medical Sciences. 2026; 14(4):425.
https://doi.org/10.3390/medsci14040425
Chicago/Turabian Style
Kaklamanos, Aimilios, Vasileios Serepisios, Sofia Chelioti, Kalliopi Zervakou, George Christodoulou, Abraham Pouliakis, Konstantina Mikelopoulou, Daphnie Germanou, Ilias Tsinokou, Dimitrios Dorotheos Papadakis,
and et al. 2026. "Intermediate-Dose Tinzaparin Versus Low-Dose Enoxaparin as Thromboprophylaxis in Hospitalized Internal Medicine Patients" Medical Sciences 14, no. 4: 425.
https://doi.org/10.3390/medsci14040425
APA Style
Kaklamanos, A., Serepisios, V., Chelioti, S., Zervakou, K., Christodoulou, G., Pouliakis, A., Mikelopoulou, K., Germanou, D., Tsinokou, I., Papadakis, D. D., Tsironis, C., & Androutsakos, T.
(2026). Intermediate-Dose Tinzaparin Versus Low-Dose Enoxaparin as Thromboprophylaxis in Hospitalized Internal Medicine Patients. Medical Sciences, 14(4), 425.
https://doi.org/10.3390/medsci14040425
